(RTTNews) - Solid Biosciences Inc. (SLDB) announced that it has received positive regulatory feedback from a recent Type C meeting with the U.S FDA, marking a key step forward for its gene therapy ...

When ice melts into water, it happens quickly, with the transition from solid to liquid being immediate. However, very thin materials do not adhere to these rules. Instead, an unusual state between ...

Roche has dropped five Chugai candidates from its clinical pipeline, echoing actions the Japanese business took earlier this year. Chugai revealed (PDF) the suspension of in-house development of the ...

Rezatapopt demonstrated a 33% overall response rate in tumors with TP53 Y220C mutations, with a median response duration of 6.2 months. The phase 2 PYNNACLE trial reported consistent safety results ...

To detect popular party drugs in human waste, researchers combined headspace solid-phase microextraction and solid-phase microextraction to detect these substances and their metabolites. South Korea ...

BOSTON--(BUSINESS WIRE)--Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 clinical data for its lead investigational candidate, ...

Phase II assessment of carboplatin with etoposide and high-dose ifosfamide in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory ...

Navy fires USS Mason commanding officer during strike drills Viral AI video of Tom Cruise fighting Brad Pitt leaves Hollywood flabbergasted: 'It's likely over for us' FDA issues highest-level warning ...

The study demonstrates that aluminum manufacturing scrap can be transformed into metal alloys through a new method called solid phase alloying that perform on par with identical materials produced ...